Cargando…
Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method
BACKGROUND: Immunohistochemistry (IHC)-based surrogate assay is the prevailing method in daily clinical practice to determine the necessity of chemotherapy for Luminal-like breast cancer patients worldwide. It relies on Ki67 scores to separate Luminal A-like from Luminal B-like breast cancer subtype...
Autores principales: | Hao, Junmei, Lyu, Yan, Zou, Jiarui, Zhang, Yunyun, Xie, Shuishan, Jing, Lili, Tang, Fangrong, Lyu, Jiahong, Zhang, Wenfeng, Zhang, Jianbo, Wang, Xunting, Chen, Kuisheng, Zhang, Jiandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485584/ https://www.ncbi.nlm.nih.gov/pubmed/34604077 http://dx.doi.org/10.3389/fonc.2021.737781 |
Ejemplares similares
-
Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using Quantitative Dot Blot (QDB) method
por: Yu, Guohua, et al.
Publicado: (2020) -
Quantitative dot blot analysis (QDB), a versatile high throughput immunoblot method
por: Tian, Geng, et al.
Publicado: (2017) -
High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis (QDB)
por: Qi, Xiaoying, et al.
Publicado: (2018) -
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021) -
Validation of absolutely quantitated Ki67 and cyclinD1 protein levels for prognosis of Luminal‐like breast cancer patients
por: Yu, Guohua, et al.
Publicado: (2022)